HedgeChatter

  • Home /
  • Tag Archives

PRAN

6:10 am Prana Biotech meets primary endpoint in Phase 2 REACH2HD clinical study of PBT2 for treating Huntington disease; preliminary evidence suggests PBT2 250mg reduced atrophy of brain tissue in areas affected in Huntington disease, seen

moreView todays social media effects on PRANView the latest stocks trending across Twitter. Click to view dashboardSee who Prana is hiring next, click here to view […]

February 18, 2014 Bystocknews , Comments Off on 6:10 am Prana Biotech meets primary endpoint in Phase 2 REACH2HD clinical study of PBT2 for treating Huntington disease; preliminary evidence suggests PBT2 250mg reduced atrophy of brain tissue in areas affected in Huntington disease, seen read more

Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease

[PR Newswire] – Secondary endpoint: Statistically significant improvement in a measure of executive function(cognition) in research participants administered 250mg PBT2 daily (p=0.042). PBT2 250mg was also associated with a favourable signal in functiona moreView todays social media effects on PRANView the latest stocks trending across Twitter. Click to view dashboardSee who Prana is hiring next, click here to view […]

February 18, 2014 Bystocknews , Comments Off on Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease read more

3 Horrendous Health-Care Stocks This Week

moreView todays social media effects on PRANView the latest stocks trending across Twitter. Click to view dashboardSee who Prana is hiring next, click here to view […]

February 15, 2014 Bystocknews , Comments Off on 3 Horrendous Health-Care Stocks This Week read more

Prana Announces $5.8 Million R&D Refund

[Marketwired] – Prana Biotechnology today reported that it has received a A$2.5 million cash refund under the R&D Tax Incentive Program, a program administered by AusIndustry and the Australian Taxation Office. This payment … moreView todays social media effects on PRANView the latest stocks trending across Twitter. Click to view dashboardSee who Prana is hiring next, click here to view […]

April 4, 2013 Bystocknews , Comments Off on Prana Announces $5.8 Million R&D Refund read more

Prana Provides Clinical Trials Safety and Progress Update

[Marketwired] – Prana Biotechnology today reported on the progress of its lead development asset PBT2 in Phase II trials for Huntington disease and Alzheimer’s disease. Across the two trials approximately 37% have been … moreView todays social media effects on PRANView the latest stocks trending across Twitter. Click to view dashboardSee who Prana is hiring next, click here to view […]

April 3, 2013 Bystocknews , Comments Off on Prana Provides Clinical Trials Safety and Progress Update read more

Prana Announces Successful A$7 million Capital Raising

[at noodls] – Melbourne – March 27, 2013 Prana Biotechnology (NASDAQ:PRAN; ASX:PBT), today announced that it has secured funding of A$7 million through a placement of approximately 35.9 million fully paid ordinary shares … moreView todays social media effects on PRANView the latest stocks trending across Twitter. Click to view dashboardSee who Prana is hiring next, click here to view […]

March 28, 2013 Bystocknews , Comments Off on Prana Announces Successful A$7 million Capital Raising read more

Prana Details Data Showing That PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation

[Marketwired] – Prana Biotechnology . Following on from the announcement released on 4th March, 2013 and at the request of the Australian Securities Exchange, the company is pleased to provide further detail in respect … moreView todays social media effects on PRANView the latest stocks trending across Twitter. Click to view dashboardSee who Prana is hiring next, click here to […]

March 8, 2013 Bystocknews , Comments Off on Prana Details Data Showing That PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation read more